Avalyn Pharma develops improved therapies for the treatment of Idiopathic Pulmonary Fibrosis (IPF).
Location: United States, Washington, Seattle
Total raised: $210.5M
Investors 8
Funding Rounds 2
| Date | Series | Amount | Investors |
| 05.10.2023 | Series C | $175M | - |
| 28.04.2020 | Series B | $35.5M | - |
Mentions in press and media 11
| Date | Title | Description | Source |
| 16.11.2023 | No new unicorns in Seattle: The billion-dollar startup miles... | (GeekWire Photo Illustration / Photo by Kevin Lisota) The unicorn stampede in Seattle has screeched... | geekwire.c... |
| 05.10.2023 | Avalyn: Targeted Inhalation Therapy Company Raises $175 Mill... | Avalyn Pharma – a clinical-stage biopharmaceutical company focused on developing targeted inhalation... | pulse2.com... |
| 03.10.2023 | VC funding to Pacific Northwest startups in Q3 was down near... | Seattle’s skyline with Mount Rainier in the background. (GeekWire Photo / Nate Bek) Pacific Northwe... | geekwire.c... |
| 29.09.2023 | Avalyn Raises $175 Million in Series C Financing | SEATTLE, WA, Avalyn Pharma Inc., a clinical-stage biopharmaceutical company, announced the closing... | vcnewsdail... |
| 27.09.2023 | Avalyn Raises $175 Million in Oversubscribed Series C Financ... | - | vidaventur... |
| 27.09.2023 | Avalyn Pharma Closes $175M Series C Financing | Avalyn Pharma Inc., a Seattle, WA-based clinical-stage biopharmaceutical company focused on developm... | finsmes.co... |
| 27.09.2023 | Avalyn raises $175M to test inhaler versions of IPF medicine... | - | fprimecapi... |
| 27.09.2023 | Avalyn Raises $175 Million in Oversubscribed Series C Financ... | - | fprimecapi... |
| 28.04.2020 | Avalyn Pharma Secures $35.5M Series B | SEATTLE, WA, Avalyn Pharma announced the completion of a $35.5 million Series B financing. >&g... | vcnewsdail... |
| 27.04.2020 | Avalyn Pharma Secures $35.5 Million Series B Financing, Broa... | - | fprimecapi... |
Show more